| SAMHD1 is mutated recurrently in chronic lymphocytic leukemia and is involved in response to DNA damage R Clifford, T Louis, P Robbe, S Ackroyd, A Burns, AT Timbs, ... Blood, The Journal of the American Society of Hematology 123 (7), 1021-1031, 2014 | 262 | 2014 |
| Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project P Robbe, N Popitsch, SJL Knight, P Antoniou, J Becq, M He, A Kanapin, ... Genetics in Medicine 20 (10), 1196-1205, 2018 | 159 | 2018 |
| Presence of multiple recurrent mutations confers poor trial outcome of relapsed/refractory CLL R Guièze, P Robbe, R Clifford, S De Guibert, B Pereira, A Timbs, ... Blood, The Journal of the American Society of Hematology 126 (18), 2110-2117, 2015 | 141 | 2015 |
| Genomic disruption of the histone methyltransferase SETD2 in chronic lymphocytic leukaemia H Parker, MJJ Rose-Zerilli, M Larrayoz, R Clifford, J Edelmann, ... Leukemia 30 (11), 2179-2186, 2016 | 83 | 2016 |
| Whole-genome sequencing of chronic lymphocytic leukaemia reveals distinct differences in the mutational landscape between IgHVmut and IgHVunmut subgroups A Burns, R Alsolami, J Becq, B Stamatopoulos, A Timbs, D Bruce, ... Leukemia 32 (2), 332-342, 2018 | 79 | 2018 |
| Genomic and transcriptomic correlates of Richter transformation in chronic lymphocytic leukemia J Klintman, N Appleby, B Stamatopoulos, K Ridout, TA Eyre, P Robbe, ... Blood, The Journal of the American Society of Hematology 137 (20), 2800-2816, 2021 | 75 | 2021 |
| Targeted deep sequencing reveals clinically relevant subclonal IgHV rearrangements in chronic lymphocytic leukemia B Stamatopoulos, A Timbs, D Bruce, T Smith, R Clifford, P Robbe, A Burns, ... Leukemia 31 (4), 837-845, 2017 | 75 | 2017 |
| Clinical significance of TP53, BIRC3, ATM and MAPK-ERK genes in chronic lymphocytic leukaemia: data from the randomised UK LRF CLL4 trial SJ Blakemore, R Clifford, H Parker, P Antoniou, E Stec-Dziedzic, ... Leukemia 34 (7), 1760-1774, 2020 | 53 | 2020 |
| The light chain IgLV3-21 defines a new poor prognostic subgroup in chronic lymphocytic leukemia: results of a multicenter study B Stamatopoulos, T Smith, E Crompot, K Pieters, R Clifford, M Mraz, ... Clinical Cancer Research 24 (20), 5048-5057, 2018 | 49 | 2018 |
| Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features P Robbe, KE Ridout, DV Vavoulis, H Dréau, B Kinnersley, N Denny, ... Nature genetics 54 (11), 1675-1689, 2022 | 33 | 2022 |
| Clinical significance of DNA methylation in chronic lymphocytic leukemia patients: results from 3 UK clinical trials TK Wojdacz, HE Amarasinghe, L Kadalayil, A Beattie, J Forster, ... Blood Advances 3 (16), 2474-2481, 2019 | 28 | 2019 |
| Classical and non-classical presentations of complement factor I deficiency: two contrasting cases diagnosed via genetic and genomic methods AM Shields, AT Pagnamenta, AJ Pollard, OxClinWGS, JC Taylor, ... Frontiers in immunology 10, 1150, 2019 | 24 | 2019 |
| Clinical‐grade validation of whole genome sequencing reveals robust detection of low‐frequency variants and copy number alterations in CLL J Klintman, K Barmpouti, SJL Knight, P Robbe, H Dreau, R Clifford, ... British journal of haematology 182 (3), 412-417, 2018 | 21 | 2018 |
| Using genomic information to guide ibrutinib treatment decisions in chronic lymphocytic leukaemia: a cost-effectiveness analysis J Buchanan, S Wordsworth, R Clifford, P Robbe, JC Taylor, A Schuh, ... Pharmacoeconomics 35, 845-858, 2017 | 16 | 2017 |
| Comparative analysis of somatic variant calling on matched FF and FFPE WGS samples L De Schaetzen van Brienen, M Larmuseau, K Van der Eecken, ... BMC Medical Genomics 13, 1-15, 2020 | 14 | 2020 |
| Genome-wide association study identifies risk loci for progressive chronic lymphocytic leukemia WY Lin, SE Fordham, N Sunter, C Elstob, T Rahman, E Willmore, ... Nature Communications 12 (1), 665, 2021 | 11 | 2021 |
| Detection of clinically relevant molecular alterations in chronic lymphocytic leukemia (CLL) by Nanopore sequencing A Burns, DR Bruce, P Robbe, A Timbs, B Stamatopoulos, R Clifford, ... Blood 132, 1847, 2018 | 3* | 2018 |
| Long-term follow-up of 415 patients with chronic lymphocytic leukaemia treated with fludarabine and cyclophosphamide-based chemoimmunotherapy in the frontline ADMIRE and ARCTIC … D Allsup, Z Craig, D Cairns, D Howard, A Hockaday, A Bloor, Z Soe, ... | 1 | 2022 |
| Genomic Stratification of Hematological Malignancies P Robbe, A Schuh HemaSphere 7 (6), e902, 2023 | | 2023 |
| Addressing challenges of molecular precision diagnostics for cancer patients in the genomics era P Robbe, A Schuh, FM Buffa University of Oxford, 2017 | | 2017 |
Anna SchuhUniversity of Oxford在 oncology.ox.ac.uk 的电子邮件经过验证
